Global Oncology Companion Diagnostic Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Technology
1.3.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Technology: 2020 VS 2026
1.3.2 Polymerase Chain Reaction (PCR)
1.3.3 Next-Generation Sequencing (NGS)
1.3.4 Immunohistochemistry (IHC)
1.3.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
1.3.6 Others
1.4 Market by Application
1.4.1 Global Oncology Companion Diagnostic Market Share by End Users: 2020 VS 2026
1.4.2 Hospital
1.4.3 Pathology/Diagnostic Laboratory
1.4.4 Academic Medical Center
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Companion Diagnostic Market Perspective (2015-2026)
2.2 Oncology Companion Diagnostic Growth Trends by Regions
2.2.1 Oncology Companion Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncology Companion Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Oncology Companion Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Oncology Companion Diagnostic Industry Dynamic
2.3.1 Oncology Companion Diagnostic Market Trends
2.3.2 Oncology Companion Diagnostic Market Drivers
2.3.3 Oncology Companion Diagnostic Market Challenges
2.3.4 Oncology Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Companion Diagnostic Players by Market Size
3.1.1 Global Top Oncology Companion Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Oncology Companion Diagnostic Revenue Market Share by Players (2015-2020)
3.2 Global Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Companion Diagnostic Revenue
3.4 Global Oncology Companion Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Companion Diagnostic Revenue in 2019
3.5 Key Players Oncology Companion Diagnostic Area Served
3.6 Key Players Oncology Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Oncology Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Companion Diagnostic Breakdown Data by Technology
4.1 Global Oncology Companion Diagnostic Historic Market Size by Technology (2015-2020)
4.2 Global Oncology Companion Diagnostic Forecasted Market Size by Technology (2021-2026)
5 Oncology Companion Diagnostic Breakdown Data by End Users
5.1 Global Oncology Companion Diagnostic Historic Market Size by End Users (2015-2020)
5.2 Global Oncology Companion Diagnostic Forecasted Market Size by End Users (2021-2026)
6 North America
6.1 North America Oncology Companion Diagnostic Market Size (2015-2026)
6.2 North America Oncology Companion Diagnostic Market Size by Technology (2015-2020)
6.3 North America Oncology Companion Diagnostic Market Size by End Users (2015-2020)
6.4 North America Oncology Companion Diagnostic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Oncology Companion Diagnostic Market Size (2015-2026)
7.2 Europe Oncology Companion Diagnostic Market Size by Technology (2015-2020)
7.3 Europe Oncology Companion Diagnostic Market Size by End Users (2015-2020)
7.4 Europe Oncology Companion Diagnostic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Companion Diagnostic Market Size (2015-2026)
8.2 Asia-Pacific Oncology Companion Diagnostic Market Size by Technology (2015-2020)
8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by End Users (2015-2020)
8.4 Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Oncology Companion Diagnostic Market Size (2015-2026)
9.2 Latin America Oncology Companion Diagnostic Market Size by Technology (2015-2020)
9.3 Latin America Oncology Companion Diagnostic Market Size by End Users (2015-2020)
9.4 Latin America Oncology Companion Diagnostic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Companion Diagnostic Market Size (2015-2026)
10.2 Middle East & Africa Oncology Companion Diagnostic Market Size by Type (2015-2020)
10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Application (2015-2020)
10.4 Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020))
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Oncology Companion Diagnostic Introduction
11.2.4 Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.2.5 Illumina, Inc. Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Details
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Oncology Companion Diagnostic Introduction
11.3.4 Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.3.5 Qiagen N.V. Recent Development
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Details
11.4.2 Thermo Fisher Scientific Inc. Business Overview
11.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Introduction
11.4.4 Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.4.5 Thermo Fisher Scientific Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 ARUP Laboratories
11.6.1 ARUP Laboratories Company Details
11.6.2 ARUP Laboratories Business Overview
11.6.3 ARUP Laboratories Oncology Companion Diagnostic Introduction
11.6.4 ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.6.5 ARUP Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Oncology Companion Diagnostic Introduction
11.7.4 Abbott Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.7.5 Abbott Recent Development
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Details
11.8.2 Myriad Genetics, Inc. Business Overview
11.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Introduction
11.8.4 Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.8.5 Myriad Genetics, Inc. Recent Development
11.9 bioMérieux SA
11.9.1 bioMérieux SA Company Details
11.9.2 bioMérieux SA Business Overview
11.9.3 bioMérieux SA Oncology Companion Diagnostic Introduction
11.9.4 bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.9.5 bioMérieux SA Recent Development
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Details
11.10.2 Invivoscribe, Inc. Business Overview
11.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Introduction
11.10.4 Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020)
11.10.5 Invivoscribe, Inc. Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Oncology Companion Diagnostic Market Size Growth Rate by Technology (US$ Million): 2020 VS 2026
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Next-Generation Sequencing (NGS)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Table 6. Key Players of Others
Table 7. Global Oncology Companion Diagnostic Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 8. Global Oncology Companion Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Oncology Companion Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Oncology Companion Diagnostic Market Share by Regions (2015-2020)
Table 11. Global Oncology Companion Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Oncology Companion Diagnostic Market Share by Regions (2021-2026)
Table 13. Oncology Companion Diagnostic Market Market Trends
Table 14. Oncology Companion Diagnostic Market Drivers
Table 15. Oncology Companion Diagnostic Market Challenges
Table 16. Oncology Companion Diagnostic Market Restraints
Table 17. Global Oncology Companion Diagnostic Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Oncology Companion Diagnostic Market Share by Players (2015-2020)
Table 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2019)
Table 20. Global Oncology Companion Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Companion Diagnostic Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 25. Global Oncology Companion Diagnostic Revenue Market Share by Technology (2015-2020)
Table 26. Global Oncology Companion Diagnostic Forecasted Market Size by Technology (2021-2026) (US$ Million)
Table 27. Global Oncology Companion Diagnostic Market Size Share by End Users (2015-2020) (US$ Million)
Table 28. Global Oncology Companion Diagnostic Revenue Market Share by End Users (2015-2020)
Table 29. Global Oncology Companion Diagnostic Forecasted Market Size by End Users (2021-2026) (US$ Million)
Table 30. North America Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 31. North America Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 32. North America Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 33. North America Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 34. North America Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 36. Europe Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 37. Europe Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 38. Europe Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 39. Europe Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 40. Europe Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 42. Asia-Pacific Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 43. Asia-Pacific Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 44. Asia-Pacific Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 45. Asia-Pacific Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 46. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (US$ Million) (2015-2020)
Table 47. Asia-Pacific Oncology Companion Diagnostic Market Share by Region (2015-2020)
Table 48. Latin America Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 49. Latin America Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 50. Latin America Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 51. Latin America Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 52. Latin America Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 53. Latin America Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 54. Middle East & Africa Oncology Companion Diagnostic Market Size by Technology (2015-2020) (US$ Million)
Table 55. Middle East & Africa Oncology Companion Diagnostic Market Share by Technology (2015-2020)
Table 56. Middle East & Africa Oncology Companion Diagnostic Market Size by End Users (2015-2020) (US$ Million)
Table 57. Middle East & Africa Oncology Companion Diagnostic Market Share by End Users (2015-2020)
Table 58. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 59. Middle East & Africa Oncology Companion Diagnostic Market Share by Country (2015-2020)
Table 60. Agilent Technologies, Inc. Company Details
Table 61. Agilent Technologies, Inc. Business Overview
Table 62. Agilent Technologies, Inc. Oncology Companion Diagnostic Product
Table 63. Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 64. Agilent Technologies, Inc. Recent Development
Table 65. Illumina, Inc. Company Details
Table 66. Illumina, Inc. Business Overview
Table 67. Illumina, Inc. Oncology Companion Diagnostic Product
Table 68. Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 69. Illumina, Inc. Recent Development
Table 70. Qiagen N.V. Company Details
Table 71. Qiagen N.V. Business Overview
Table 72. Qiagen N.V. Oncology Companion Diagnostic Product
Table 73. Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 74. Qiagen N.V. Recent Development
Table 75. Thermo Fisher Scientific Inc. Company Details
Table 76. Thermo Fisher Scientific Inc. Business Overview
Table 77. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product
Table 78. Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 79. Thermo Fisher Scientific Inc. Recent Development
Table 80. F. Hoffmann-La Roche Ltd. Company Details
Table 81. F. Hoffmann-La Roche Ltd. Business Overview
Table 82. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product
Table 83. F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 84. F. Hoffmann-La Roche Ltd. Recent Development
Table 85. ARUP Laboratories Company Details
Table 86. ARUP Laboratories Business Overview
Table 87. ARUP Laboratories Oncology Companion Diagnostic Product
Table 88. ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 89. ARUP Laboratories Recent Development
Table 90. Abbott Company Details
Table 91. Abbott Business Overview
Table 92. Abbott Oncology Companion Diagnostic Product
Table 93. Abbott Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 94. Abbott Recent Development
Table 95. Myriad Genetics, Inc. Business Overview
Table 96. Myriad Genetics, Inc. Oncology Companion Diagnostic Product
Table 97. Myriad Genetics, Inc. Company Details
Table 98. Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 99. Myriad Genetics, Inc. Recent Development
Table 100. bioMérieux SA Company Details
Table 101. bioMérieux SA Business Overview
Table 102. bioMérieux SA Oncology Companion Diagnostic Product
Table 103. bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 104. bioMérieux SA Recent Development
Table 105. Invivoscribe, Inc. Company Details
Table 106. Invivoscribe, Inc. Business Overview
Table 107. Invivoscribe, Inc. Oncology Companion Diagnostic Product
Table 108. Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2015-2020) (US$ Million)
Table 109. Invivoscribe, Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Oncology Companion Diagnostic Market Share by Technology: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Next-Generation Sequencing (NGS) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features
Figure 6. Others Features
Figure 7. Global Oncology Companion Diagnostic Market Share by End Users: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Pathology/Diagnostic Laboratory Case Studies
Figure 10. Academic Medical Center Case Studies
Figure 11. Oncology Companion Diagnostic Report Years Considered
Figure 12. Global Oncology Companion Diagnostic Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Oncology Companion Diagnostic Market Share by Regions: 2020 VS 2026
Figure 14. Global Oncology Companion Diagnostic Market Share by Regions (2021-2026)
Figure 15. Global Oncology Companion Diagnostic Market Share by Players in 2019
Figure 16. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Companion Diagnostic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2019
Figure 18. North America Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Oncology Companion Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Agilent Technologies, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 44. Illumina, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 45. Qiagen N.V. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 48. ARUP Laboratories Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 49. Abbott Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 50. Myriad Genetics, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 51. bioMérieux SA Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 52. Invivoscribe, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed